Accessibility Menu
 
Kane Biotech logo

Kane Biotech

(OTC) KNBIF

Current Price$0.03
Market Cap$6.02M
Since IPO (2011)-94%
5 Year-82%
1 Year-44%
1 Month+50%

Kane Biotech Financials at a Glance

Market Cap

$6.02M

Revenue (TTM)

$427.52K

Net Income (TTM)

$2.72M

EPS (TTM)

$-0.01

P/E Ratio

-3.80

Dividend

$0.00

Beta (Volatility)

-0.00 (Low)

Price

$0.03

Volume

30,000

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.02 - $0.06

KNBIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kane Biotech

Industry

Biotechnology

CEO

Robert B. Huizinga, PhD

Headquarters

Winnipeg, MB R3T 6G2, CA

KNBIF Financials

Key Financial Metrics (TTM)

Gross Margin

-38%

Operating Margin

-7%

Net Income Margin

-6%

Return on Equity

0%

Return on Capital

-13%

Return on Assets

-100%

Earnings Yield

-26.32%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.02M

Shares Outstanding

181.86M

Volume

30.00K

Avg. Volume

10.68K

Financials (TTM)

Gross Profit

$163.24K

Operating Income

$3.11M

EBITDA

$2.95M

Operating Cash Flow

$3.25M

Capital Expenditure

$4.89K

Free Cash Flow

$3.26M

Cash & ST Invst.

$900.96K

Total Debt

$2.30M

Kane Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$21.49K

-117.1%

Gross Profit

$155.04K

-77.8%

Gross Margin

7.21%

N/A

Market Cap

$6.02M

N/A

Market Cap/Employee

$300.98K

N/A

Employees

20

N/A

Net Income

$544.64K

+49.7%

EBITDA

$1.14M

-19.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.40M

+22.8%

Accounts Receivable

$36.46K

-58.6%

Inventory

$504.15K

+34.1%

Long Term Debt

$977.91K

-42.9%

Short Term Debt

$1.32M

+186.9%

Return on Assets

-99.53%

N/A

Return on Invested Capital

-13.41%

N/A

Free Cash Flow

$582.74K

-26.4%

Operating Cash Flow

$677.96K

-61.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BUDZWEED, Inc.
$0.04+3.90%
PMEDFQscreen Ai Inc.
$0.03-6.06%
BIXTBioxytran, Inc.
$0.03-7.98%
FAMDFFutura Medical plc
$0.03+200.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
AAPLApple
$280.14+0.03%

Questions About KNBIF

What is the current price of Kane Biotech?

Kane Biotech is trading at $0.03 per share.

What is the 52-week range for Kane Biotech?

Over the past 52 weeks, Kane Biotech has traded between $0.02 and $0.06.

How much debt does Kane Biotech have?

As of the most recent reporting period, Kane Biotech reported total debt of $1.65M.

How much cash does Kane Biotech have on hand?

Kane Biotech reported $674,904.413 in cash and cash equivalents in its most recent financial results.

What is Kane Biotech’s dividend yield?

Kane Biotech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.